Page last updated: 2024-10-28

hexamethonium and Amentia

hexamethonium has been researched along with Amentia in 1 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lhermite, A1
Munoz Sastre, MT1
Sorum, PC1
Mullet, E1

Other Studies

1 other study available for hexamethonium and Amentia

ArticleYear
Decision-Making Capacity Among Elderly People: A Mapping of Health Professionals' and Laypeople's Views.
    International journal of aging & human development, 2019, Volume: 89, Issue:3

    Topics: Adult; Aged; Aging; Attitude of Health Personnel; Attitude to Health; Decision Making; Dementia; Fem

2019